Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00003895
Status:
COMPLETED
Last Update Posted:
2017-02-20
First Post:
1999-11-01
Brief Title:
Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IIIC Melanoma |
| Recurrent Melanoma |
| Stage IA Melanoma |
| Stage IB Melanoma |
| Stage IIA Melanoma |
| Stage IIB Melanoma |
| Stage IIC Melanoma |
| Stage IIIA Melanoma |
| Stage IIIB Melanoma |
Keywords: